What smart money is saying about Healthpeak
PEAK
No fund has written a full thesis on Healthpeak in our archive, but 1 fund letter reports a position in it, most recently Schafer Cullen High Dividend Value in December 2025.
Get an email when a fund buys, sells or pitches it
1
Reported positions
0
Bought
0
Sold
1
Letter
Position history
Every position in Healthpeak on record in the archive was reported in Q4 2025, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q4 2025 | 1 | 0 | 0 | 0 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 1 position
- December 2025
“Our overweight allocation to and stock selection within the Real Estate sector detracted from relative performance. Real Estate was the worst-performing sector in the quarter, weighed down by elevated interest rates and still-struggling fundamentals in much of the commercial property market. Healthpeak (-14.5%) underperformed due to the uncertainty in the life science property market, where supply and demand metrics are still challenging in the major markets of San Francisco, Boston and San Diego.”
Healthpeak
Read the letters behind these Healthpeak positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves, and to Warren AI, which reads all of them for you.
View plans→Share this ledger